These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. Benigni A; Gregorini G; Frusca T; Chiabrando C; Ballerini S; Valcamonico A; Orisio S; Piccinelli A; Pinciroli V; Fanelli R N Engl J Med; 1989 Aug; 321(6):357-62. PubMed ID: 2664523 [TBL] [Abstract][Full Text] [Related]
3. Umbilical cord serum levels of thromboxane B2 in term infants of women who participated in a placebo-controlled trial of low-dose aspirin. Parker CR; Hauth JC; Goldenberg RL; Cooper RL; Dubard MB J Matern Fetal Med; 2000; 9(4):209-15. PubMed ID: 11048830 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955 [TBL] [Abstract][Full Text] [Related]
5. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers. Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674 [TBL] [Abstract][Full Text] [Related]
6. Plasma levels of salicylate and aspirin in healthy volunteers: relevance to drug interaction on platelet function. Cerletti C; Bonati M; del Maschio A; Galletti F; Dejana E; Tognoni G; de Gaetano G J Lab Clin Med; 1984 Jun; 103(6):869-77. PubMed ID: 6726057 [TBL] [Abstract][Full Text] [Related]
7. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". Santilli F; Rocca B; De Cristofaro R; Lattanzio S; Pietrangelo L; Habib A; Pettinella C; Recchiuti A; Ferrante E; Ciabattoni G; Davì G; Patrono C J Am Coll Cardiol; 2009 Feb; 53(8):667-77. PubMed ID: 19232899 [TBL] [Abstract][Full Text] [Related]
8. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy. Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of copper-aspirin complex on platelet aggregation. Shen ZQ; Chen ZH; Ma GY; Wang DC; Wu WL; Liu WP; Yang YK; Xiong HZ Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):358-62. PubMed ID: 10072923 [TBL] [Abstract][Full Text] [Related]
10. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism. Dale J; Thaulow E; Myhre E; Parry J Thromb Haemost; 1983 Oct; 50(3):703-6. PubMed ID: 6689091 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin. Preston FE; Whipps S; Jackson CA; French AJ; Wyld PJ; Stoddard CJ N Engl J Med; 1981 Jan; 304(2):76-9. PubMed ID: 7003384 [TBL] [Abstract][Full Text] [Related]
12. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100. Homoncik M; Jilma B; Hergovich N; Stohlawetz P; Panzer S; Speiser W Thromb Haemost; 2000 Feb; 83(2):316-21. PubMed ID: 10739392 [TBL] [Abstract][Full Text] [Related]
13. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists. Zucker ML; Budd SE; Dollar LE; Chernoff SB; Altman R Thromb Haemost; 1993 Aug; 70(2):332-5. PubMed ID: 8236144 [TBL] [Abstract][Full Text] [Related]
14. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women. Ridker PM; Hennekens CH; Tofler GH; Lipinska I; Buring JE J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865 [TBL] [Abstract][Full Text] [Related]
15. Virgin olive oil polyphenol hydroxytyrosol acetate inhibits in vitro platelet aggregation in human whole blood: comparison with hydroxytyrosol and acetylsalicylic acid. Correa JA; López-Villodres JA; Asensi R; Espartero JL; Rodríguez-Gutiérez G; De La Cruz JP Br J Nutr; 2009 Apr; 101(8):1157-64. PubMed ID: 18775097 [TBL] [Abstract][Full Text] [Related]
16. Neonatal platelet reactivity and serum thromboxane B2 production in whole blood: the effect of maternal low dose aspirin. Louden KA; Broughton Pipkin F; Heptinstall S; Fox SC; Tuohy P; O'Callaghan C; Mitchell JR; Symonds EM Br J Obstet Gynaecol; 1994 Mar; 101(3):203-8. PubMed ID: 8193093 [TBL] [Abstract][Full Text] [Related]
17. Failure of aspirin to impair bovine platelet function. Gentry PA; Tremblay RR; Ross ML Am J Vet Res; 1989 Jun; 50(6):919-22. PubMed ID: 2764343 [TBL] [Abstract][Full Text] [Related]
18. Dose- and time-dependent antiplatelet effects of aspirin. Perneby C; Wallén NH; Rooney C; Fitzgerald D; Hjemdahl P Thromb Haemost; 2006 Apr; 95(4):652-8. PubMed ID: 16601836 [TBL] [Abstract][Full Text] [Related]
19. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets. Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903 [TBL] [Abstract][Full Text] [Related]
20. Pilot trial of the effects of low-dose acetylsalicylic acid on platelet thromboxane B2 production. Janssen PL; Akkerman JW; Hollman PC; van Staveren WA; Zwaginga JJ; Katan MB Eur J Clin Nutr; 1995 May; 49(5):365-70. PubMed ID: 7664723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]